Previous 10 | Next 10 |
Insider activity is getting increasingly informative to follow up during this tough market environment. Insider activity declined significantly in November, indicating that they believe the market is overvalued. However, one can still find very interesting stocks by following sign...
‒ The GP2 Phase III clinical trial design was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) and introduced by the Global Principal Investigator, Professor Mothaffar F. Rimawi of Baylor College of Medicine ‒ In the Phase IIb clinical trial, led b...
Gainers: Immutep (IMMP) +166%.SELLAS Life Sciences (SLS) +90%.Neos Therapeutics (NEOS) +65%.Greenwich LifeSciences (GLSI) +51%.Aytu BioScience (AYTU) +34%.Veru (VERU) +34%.Silver Spike Acquisition (SSPK) +32%.8x8 (EGHT) +32%.TG Therapeutics (TGTX) +31%.Peabody Energy (BTU) +29%...
Yesterday, shares of small-cap biotech Greenwich LifeSciences (NASDAQ: GLSI) surged by nearly 3,000% to an all-time high of $158.07. Today, shares are priced at $90.57, representing stock price growth of 1,650% in two days. The wild trading followed the announcement of positive clin...
Gainers: Immutep (IMMP) +204%, Greenwich LifeSciences (GLSI) +60%, TG Therapeutics (TGTX) +37%, SELLAS Life Sciences (SLS) +28%, Anixa Biosciences (ANIX) +18%.Losers: Xenetic Biosciences (XBIO) -32%, Oncternal Therapeutics (ONCT)-26%, GeoVax L...
Should You Buy These Biotech Stocks Right Now? Biotech stocks are taking the stock market by storm again this week. This came after Greenwich Life Sciences ( GLSI Stock Report ) announced a major breakthrough in its cancer treatment candidate. The company’s poster...
Immutep (IMMP) +132% after breast cancer trial shows promising survival data.Greenwich LifeSciences (GLSI) +57%.UTStarcom Holdings (UTSI) +50%.Panbela Therapeutics (PBLA) +46%.Leju Holdings (LEJU) +38%.SELLAS Life Sciences (SLS) +36%.ClearOne (CLRO) +35% to expand its footprint in M...
The stock market momentarily lost some of its upward momentum on Wednesday, giving back a small portion of its gains over the past month. Most market participants blamed the downdraft on Washington's failure to make any further progress toward approving a stimulus spending package, as lawma...
The following slide deck was published by Greenwich LifeSciences, Inc. in conjunction with this event. For further details see: Greenwich LifeSciences (GLSI) Investor Presentation - Slideshow
When Penny Stocks Breakout, They Breakout Big When penny stocks swing for the fences, sometimes even the staunchest of opponents can’t help but be impressed. For those of you just signing on today, shares of Greenwich LifeSciences Inc. ( GLSI Stock Report ) went absol...
News, Short Squeeze, Breakout and More Instantly...
Greenwich LifeSciences Inc. Company Name:
GLSI Stock Symbol:
NASDAQ Market:
Greenwich LifeSciences Inc. Website:
2024-07-11 21:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAFFORD, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, tod...
STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer r...